X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.35
Delayed Data
As of Feb 27
 -0.0499 / -2.08%
Today’s Change
1.55
Today|||52-Week Range
5.04
+18.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.00937.6K2.4M
 
 
 
Cost of Goods Sold0.000.00287.9K530.5K
 
 
 
Depreciation And Amortization42.0K93.6K135.9K312.9K
 
 
 
 
 
 
Operating ExpensesGross Income-42.0K-93.6K513.8K1.5M
 
 
 
 
 
General Expenses1.2M1.1M3.7M3.8M
 
 
 
 
 
Other Operating Expenses-0.000.000.000.00
 
 
 
Research And Development32.0K69.7K99.0K113.3K
 
 
 
 
 
Total Operating Expenses1.3M1.2M4.1M4.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.3M-1.2M-3.2M-2.2M
 
 
 
 
 
Extraordinary Credit0.000.00794.7K10.0K
 
 
 
Extraordinary Charge0.000.00---1.7M
 
 
Equity In Earnings0.000.00568.8K-847.3K
 
 
 
Other Expenses27.0K5.0K9.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3M-1.2M-2.3M-2.9M
 
 
 
 
 
Minority Interest0.000.00-351.9K-1.2M
 
 
 
Net Income-1.3M-1.2M-1.4M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.7M10.1M10.9M11.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.7M10.1M10.9M11.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.12-$0.12-$0.22
 
 
 
 
 
EPS Diluted-$0.22-$0.12-$0.12-$0.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account